Skip to main content
Atrás
Watch Compare

Shuttle Pharmaceuticals Holdings, Inc.

Calidad de datos: 83%
SHPH
Nasdaq Manufacturing Chemicals
$0.73
▼ $0.03 (-3.33%)
Cap. Mercado: 4.05 M
Precio
$0.73
Cap. Mercado
4.05 M
Rango del Día
$0.70 — $0.73
Rango de 52 Semanas
$0.50 — $12.45
Volumen
33,713
Apertura $0.70
Promedio 50D / 200D
$1.19
38.84% below
Promedio 50D / 200D
$2.58
71.93% below

Quick Summary

Puntos Clave

Negative free cash flow of -9.48 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-468.90%
Below sector avg (-51.02%)
ROIC-349.35%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio1.66
Interest CoverageN/A

Valoración

PE (TTM)
-0.35
Above sector avg (-1.98)
P/B Ratio2.91
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -0.4 -2.0
P/B 2.9 5.1
ROE % -468.9 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -11.72 M
ROE -468.90% ROA -259.12%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -9.48 M
ROIC -349.35% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.66
Interest Coverage N/A Asset Turnover N/A
Working Capital 1.30 M Tangible Book Value 1.39 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.35 Forward P/E N/A
P/B Ratio 2.91 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -233.87%
Market Cap 4.05 M Enterprise Value 1.96 M
Per Share
EPS (Diluted TTM) -7.16 Revenue / Share N/A
FCF / Share -1.70 OCF / Share -1.70
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 80.89%
SBC-Adj. FCF -10.27 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue — — — —
Net Income -11.72 M -9.14 M -6.59 M -3.03 M
EPS (Diluted) -7.16 -3.30 -0.44 —
Gross Profit — — — —
Operating Income -11.92 M -7.70 M -5.89 M -2.55 M
EBITDA — — — —
R&D Expenses 4.05 M 3.62 M 3.52 M 1.49 M
SG&A Expenses — — — —
D&A 290,107.0 — — —
Interest Expense — 100,000.0 2.12 M 917,879.0
Income Tax — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 10.48 M 2.51 M 5.95 M 8.65 M
Total Liabilities 8.22 M 1.80 M 1.90 M 975,676.0
Shareholders' Equity 2.25 M 709,152.0 4.06 M 7.68 M
Total Debt — — — 91,021.0
Cash & Equivalents 334,005.0 1.92 M 2.58 M 8.42 M
Current Assets 502,911.0 2.21 M 5.59 M 8.58 M
Current Liabilities 7.97 M 1.53 M 1.04 M 975,676.0